TrialJournal for immunotherapy of cancer2019

Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma.

Mouhammed Amir Habra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.